JPH0635966B2 - Analytical reagent useful for detecting thiol compound and detection method using the same - Google Patents
Analytical reagent useful for detecting thiol compound and detection method using the sameInfo
- Publication number
- JPH0635966B2 JPH0635966B2 JP63021427A JP2142788A JPH0635966B2 JP H0635966 B2 JPH0635966 B2 JP H0635966B2 JP 63021427 A JP63021427 A JP 63021427A JP 2142788 A JP2142788 A JP 2142788A JP H0635966 B2 JPH0635966 B2 JP H0635966B2
- Authority
- JP
- Japan
- Prior art keywords
- thiol compound
- reagent
- iron
- complex
- thiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 39
- -1 thiol compound Chemical class 0.000 title claims description 19
- 238000001514 detection method Methods 0.000 title description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 239000003446 ligand Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 4
- 230000009918 complex formation Effects 0.000 claims 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 13
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000758 substrate Substances 0.000 description 7
- 150000003573 thiols Chemical class 0.000 description 7
- 239000000080 wetting agent Substances 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229940048961 cholinesterase Drugs 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UPLLQJUZZIYKHI-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;2-oxobutanedioic acid Chemical compound OC(=O)CC(=O)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O UPLLQJUZZIYKHI-DFWYDOINSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- GFFIJCYHQYHUHB-UHFFFAOYSA-N 2-acetylsulfanylethyl(trimethyl)azanium Chemical group CC(=O)SCC[N+](C)(C)C GFFIJCYHQYHUHB-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical class NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- RSJDEVMJZLLAHS-UHFFFAOYSA-N N-[phenyl(pyridin-2-yl)methylidene]hydroxylamine Chemical class C=1C=CC=NC=1C(=NO)C1=CC=CC=C1 RSJDEVMJZLLAHS-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 229930182475 S-glycoside Natural products 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 241000425573 Talanes Species 0.000 description 1
- 102000005488 Thioesterase Human genes 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical group CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002152 aqueous-organic solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- FNEPSTUXZLEUCK-UHFFFAOYSA-N benzo-15-crown-5 Chemical compound O1CCOCCOCCOCCOC2=CC=CC=C21 FNEPSTUXZLEUCK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- AWBGQVBMGBZGLS-UHFFFAOYSA-N butyrylthiocholine Chemical compound CCCC(=O)SCC[N+](C)(C)C AWBGQVBMGBZGLS-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003252 quinoxalines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000004905 tetrazines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 150000003555 thioacetals Chemical class 0.000 description 1
- 108020002982 thioesterase Proteins 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003569 thioglycosides Chemical class 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Description
【発明の詳細な説明】 発明の分野 本発明は、反応工程で一時的に発生するチオール化合物
をはじめとする、液体系中のチオール化合物を測定する
ための分析試薬及び方法に関する。更に詳しくは、本発
明の分析試薬及び方法は、チオール化合物の比色分析に
関するものであり、チオール化合物の存在に関連した
り、その原因となる試薬又は酵素の存在の測定に用いる
ことができる。Description: FIELD OF THE INVENTION The present invention relates to analytical reagents and methods for measuring thiol compounds in liquid systems, including thiol compounds that are transiently generated during the reaction process. More specifically, the analytical reagent and method of the present invention relate to the colorimetric analysis of thiol compounds and can be used to measure the presence of a thiol compound or the presence of a reagent or enzyme that causes it.
発明の背景 チオール化合物は天然に存在し、また、化学反応によっ
て製造することもできる。かかる反応としては、次式: のようなジスルフィドの還元反応及び生化学的反応を挙
げることができる。Background of the Invention Thiol compounds occur naturally and can also be prepared by chemical reactions. Such a reaction has the following formula: Examples thereof include reduction reaction and biochemical reaction of disulfide.
数多くの方法がチオール基を含む化合物の検出に関して
公知である。特に有用であり、しばしば引用される方法
は、G.K.EllmanによってArch.Biochem.Biophys.,第82
巻70〜77頁(1959年)に記載されているものである。こ
の方法は、3−メルカプト−6−ニトロ−安息香酸の黄
色のアニオンを生成する3,3′−ジチオービス−6−
ニトロ安息香酸(Ellman試薬)とのチオール反応に基づ
くものである。Many methods are known for the detection of compounds containing thiol groups. A particularly useful and often cited method is described by GK Ellman in Arch. Biochem. Biophys.
Volume 70-77 (1959). This method produces 3,3'-dithio-bis-6-, which produces the yellow anion of 3-mercapto-6-nitro-benzoic acid.
It is based on the thiol reaction with nitrobenzoic acid (Ellman's reagent).
しかしながら、Ellman法の一つの欠点は、還元されたジ
スルフィド類によって黄色の色合いのみしか生じないと
いう事である。赤色又は青色領域の色合いが出れば、通
常、はるかに望ましいと考えられており、したがって、
チオール類の視覚測定により、より適するであろう。However, one drawback of the Ellman method is that the reduced disulfides produce only a yellow shade. It is usually considered much more desirable to have a tint in the red or blue region, and thus
It may be more suitable by visual measurement of thiols.
したがって、本発明の目的は、試薬及び方法によって与
えられる色が赤又は青の領域である、チオール化合物を
比色分析するための、信頼性があり、正確で安価な分析
試薬及び方法を提供することである。Accordingly, it is an object of the present invention to provide a reliable, accurate and inexpensive analytical reagent and method for the colorimetric analysis of thiol compounds, where the color provided by the reagent and method is in the red or blue region. That is.
本発明の他の目的は、本明細書及び請求項を読めば当業
者に明らかになろう。Other objects of the invention will be apparent to those skilled in the art upon reading the specification and claims.
好ましい実施態様の詳細な説明 本発明の試薬及び方法は、次の反応式に関するものであ
る。Detailed Description of the Preferred Embodiments The reagents and methods of the present invention relate to the following reaction schemes.
2R-SH+2Fe3+→R-S-S-R+2Fe2+ この反応において、チオール化合物は+3の酸化状態の
鉄と相互作用し、該イオンを+2の状態に還元せしめ、
これによって、該チオール化合物を酸化せしめてジスル
フィドを形成せしめる。得られるFe2+イオンは好適な
リガンドと錯体を形成し、色変化を起こすことができ
る。本方法においてFe3+のモル減少率(molar extinc
tion)、及び発色リガンド:Fe2+錯体によって得られ
る色変化は、系中に最初に存在しているチオール化合物
の量に直接関連する。2R-SH + 2Fe 3+ → RSS-R + 2Fe 2+ In this reaction, the thiol compound interacts with iron in the +3 oxidation state, reducing the ion to the +2 state,
This oxidizes the thiol compound to form a disulfide. The resulting Fe 2+ ions can form a complex with a suitable ligand to cause a color change. In this method, the molar reduction rate of Fe 3+ (molar extinc
and the color change obtained by the chromogenic ligand: Fe 2+ complex is directly related to the amount of thiol compound initially present in the system.
数多くの方法が、発色錯体として好適な錯体リガンドに
よるFe2+イオンの検出に関して公知である。この目的
のために好適なリガンドの例としては、フェロイン類、
クプロイン類及びテロイン類からなる群より選択される
化合物が挙げられる。特に好適な錯体リガンドとして
は、ヒドラゾン類及びその互変異性アゾ体、テトラゾイ
ルピリジン類、ピリジルキゾリン類、ビス−イソキノリ
ン類、イミン類、フェナントロリン類、ビピリジン類、
ターピリジン類、ビジアジン類、ピリジルジアジン類、
ピリジルベンズイミダゾール類、ジアジルトリアジン
類、o−ニトロアニリン類、フェノール類、テトラジン
類、トリアジン類、ピリジン類、フェナジン類、キノキ
サリン類、ベンズイミダゾール類、置換メチル又はフェ
ニル−2−ピリジルケトン類のオキシム類が挙げられる
[Smith,Analyt.Chem.,26,1534〜1538(1954年);Schil
tら,Talanta,15,475〜478(1968年);Schiltら,Talan
ta,15,1055〜1058(1968年);及び、Schiltら,Talant
a,16,448〜452(1969年)]。他の錯体リガンドに関する記
載は、BlandamerらのJ.Chem.Soc.,Dalton 1001〜1008(1
978年)、CaseのJ.Org.Chem.,31,2398〜2400(1966年)
に、また、英国特許出願第701,843号において見られ
る。もちろん、ここに示したもの以外の錯体リガンドを
用いることもできる。Numerous methods are known for the detection of Fe 2+ ions with complex ligands suitable as chromophoric complexes. Examples of suitable ligands for this purpose include ferroins,
There may be mentioned a compound selected from the group consisting of cuproins and teloins. Particularly preferred complex ligands are hydrazones and their tautomeric azo forms, tetrazoylpyridines, pyridylquizolines, bis-isoquinolines, imines, phenanthrolines, bipyridines,
Terpyridines, vidazines, pyridyldiazines,
Pyridylbenzimidazoles, diazyltriazines, o-nitroanilines, phenols, tetrazines, triazines, pyridines, phenazines, quinoxalines, benzimidazoles, substituted methyl or phenyl-2-pyridylketone oximes And the like [Smith, Analyt. Chem., 26, 1534-1538 (1954); Schil
t et al., Talanta, 15, 475-478 (1968); Schilt et al., Talan.
ta, 15, 1055-1058 (1968); and Schilt et al., Talant.
a, 16,448-452 (1969)]. For a description of other complex ligands, see Blandamer et al., J. Chem. Soc., Dalton 1001-1008 (1.
978), Case J. Org. Chem., 31, 2398-2400 (1966)
And also in British Patent Application No. 701,843. Of course, complex ligands other than those shown here can also be used.
試験片型材中に錯体リガンドを組み込んで本発明の実施
態様を用いる場合には、疎水性基又はイオン交換官能基
も有するようにすることが有利である。これによって錯
体リガンドのマトリクスへの結合が改善され、それによ
って試験片が「ブリード」するのが防止される。用いる
ことができる疎水性基の例としては、長鎖のアルキル又
はアラルキル基が挙げられる。錯体リガンドのポリマー
結合も考えられる。When incorporating a complex ligand into the test strip template and using embodiments of the present invention, it is advantageous to also have hydrophobic or ion-exchange functional groups. This improves the binding of the complex ligand to the matrix, which prevents the specimen from "bleeding". Examples of hydrophobic groups that can be used include long chain alkyl or aralkyl groups. Polymer binding of complex ligands is also contemplated.
本発明によれば、該試験用試薬をリポン酸アミド(lipon
ic acid amide)、チオコリン、グルタチオン又は補酵素
Aのようなチオール類、あるいはチオグリコシド類のチ
オール類を検出するために用いることができる。更に、
チオエステル、チオエーテル、ジスルフィド又はチオア
セタールが試験系において生成する場合などにチオール
前駆物質を検出することもできる。According to the invention, the test reagent is a liponamide (liponamide)
can be used to detect thiols such as ic acid amide), thiocholine, glutathione or coenzyme A, or thioglycosides. Furthermore,
A thiol precursor can also be detected, such as when a thioester, thioether, disulfide or thioacetal is produced in the test system.
本発明の試験用試薬は、チオエーテルヒドロラーゼ類、
チオエステラーゼ類又はチオグリコシダーゼ類のような
チオ化合物を開裂する酵素を分析するのに好適である。
更に、コリンエステラーゼ(CHE)のようなエステラ
ーゼ類も検出することができる。CHEの通常の基質は
アセチルコリンであるが、この酵素はアセチル−及びブ
チリルチオコリンを開裂することもでき、該試験用試薬
は開裂によって生成する遊離チオール基を検出すること
ができる。本発明はまた、還元されたニコチンアミドア
デニンジヌクレオチド(NADH)の存在下での、エポ
ンアミドデヒドロゲナーゼ(liponamide dehydrogenase)
を触媒として用いるリポン酸(liponic acid)の還元のよ
うな酸化還元反応によって遊離チオール基が生成する生
化学的反応と共に用いることもできる。The test reagent of the present invention is a thioether hydrolase,
It is suitable for assaying enzymes that cleave thio compounds such as thioesterases or thioglycosidases.
Furthermore, esterases such as cholinesterase (CHE) can also be detected. A common substrate for CHE is acetylcholine, but this enzyme can also cleave acetyl- and butyrylthiocholine, and the test reagent can detect the free thiol group produced by the cleavage. The present invention also provides a liponamide dehydrogenase in the presence of reduced nicotinamide adenine dinucleotide (NADH).
It can also be used with biochemical reactions where free thiol groups are generated by redox reactions such as the reduction of liponic acid using as a catalyst.
したがって、本発明の試験用試薬は、NADHによる反
応の分析に用いることができる。NADHによる酵素の
典型例としては、ラクテートデヒドロゲナーゼ、アルコ
ールデヒドロゲナーゼ、グルコースデヒドロゲナーゼ、
グリセロールアルデヒドデヒドロゲナーゼ、グリセロー
ルホスフェートデヒドロゲナーゼ、マレートデヒドロゲ
ナーゼなどが挙げられる。NADHはまた、グルタメー
トオキサルアセテートトランスアミナーゼ(EC 2.
6.11)、グルタメートピルベートトランスアミナー
ゼ(EC 2.6.12)又はクレアチニンキナーゼ
(EC 2.7.32)の分析の場合のように、多段酵
素反応の最終生成物であってもよい。Therefore, the test reagent of the present invention can be used for analysis of a reaction by NADH. Typical examples of the enzyme by NADH include lactate dehydrogenase, alcohol dehydrogenase, glucose dehydrogenase,
Glycerol aldehyde dehydrogenase, glycerol phosphate dehydrogenase, malate dehydrogenase and the like can be mentioned. NADH is also a glutamate oxal acetate transaminase (EC 2.
It may also be the end product of a multi-step enzymatic reaction, as in the case of analysis of 6.11), glutamate pyruvate transaminase (EC 2.6.12) or creatinine kinase (EC 2.7.32).
NADHはまた、ラクテート、グルコース、マレート、
尿素などのような基質の分析においては反応生成物であ
ってもよい。NADHによる反応の分析において本発明
の試験用試薬を用いることにより、NADH1モルあた
り2モルのFe2+が生成し、いくつかの場合の発色錯体
が非常に高い吸光係数を有するので感度が実質的に向上
する。NADH also includes lactate, glucose, malate,
It may be a reaction product in the analysis of a substrate such as urea. The use of the test reagents of the invention in the analysis of reactions with NADH yields 2 moles of Fe 2+ per mole of NADH, and in some cases the chromophoric complex has a very high extinction coefficient which results in a substantial sensitivity. Improve to.
チオール基質に結合しているFe3+錯体を提供すること
が有利であることが証明され、可能な錯体形成用試薬
は、EDTA、HEDTA、クエン酸、リンゴ酸、乳
酸、例えばアラニン、グリシン、及びグルタミンのよう
なアミノ酸類、例えば18−クラウン−6、フェニルア
ザ−15−クラウン−5、ベンゾ−15−クラウン−5
及びジベンゾピリジノ−15−クラウン−5のようなク
ラウンエーテル類、又はトリアジノファン類及びクリプ
テート類である。It has proved to be advantageous to provide Fe 3+ complexes bound to thiol substrates and possible complexing reagents are EDTA, HEDTA, citric acid, malic acid, lactic acid such as alanine, glycine, and Amino acids such as glutamine, eg 18-crown-6, phenylaza-15-crown-5, benzo-15-crown-5.
And crown ethers such as dibenzopyridino-15-crown-5, or triazinophanes and cryptates.
チオール:Fe3+の濃度比は少なくとも1:1でなけれ
ばならず、好ましくは約1:5である。反応を最も早く
するためには1:10の比も好ましいが、1:20の比
が特に好ましい。The concentration ratio of thiol: Fe 3+ should be at least 1: 1 and preferably about 1: 5. A ratio of 1:10 is also preferred for the fastest reaction, but a ratio of 1:20 is particularly preferred.
本発明に関する試験用試薬又は試験系を用いてセル中の
分析対象物を測定することができる。Fe3+イオン及び
錯体リガンドに加えて、該試験用試薬は、酵素、基質、
補酵素、エフェクター、抗原、抗体などのような、特定
の分析に必要なすべての試薬を含有することもできる。
これらの試験用試薬は、緩衝剤、湿潤剤及び安定化剤の
ような、反応しない物質を含有することができる。The test reagent or test system of the present invention can be used to measure the analyte in the cell. In addition to Fe 3+ ions and complex ligands, the test reagents include enzymes, substrates,
It may also contain all reagents necessary for a particular assay, such as coenzymes, effectors, antigens, antibodies and the like.
These test reagents can contain non-reactive substances such as buffering agents, wetting agents and stabilizing agents.
上記記載のように、NADH及びNADPHを補酵素と
して用いてチオール基を生成する酵素、例えばリポンア
ミドデヒドロゲナーゼ及びグルタチオンレダクターゼを
測定することができる。試薬配合物を酵素、試薬及び既
に述べた物質から調製することができ、また、溶液又は
粉末として又は錠剤もしくは凍結乾燥物の形態で混合す
ることができる。試薬配合物は既に溶液状態になっては
いない場合は、水又は他の好適な溶液中に溶解すること
ができ、試薬溶液はこれによって調製される。試薬配合
物が個々の成分からなる場合は、これらを互いに混合す
る。試料(例えば基質溶液、酵素溶液、血清、血漿又は
尿)を試薬混合物の一部と混合した後に、得られた色を
光度計で測定する。次に、特定の濃度、又は基質濃度
を、モル吸光係数及び加えた試薬又は試料の量から計算
する。動的測定及び終点測定のいずれも可能である。As described above, NADH and NADPH can be used as coenzymes to measure enzymes that generate thiol groups, such as liponamide dehydrogenase and glutathione reductase. Reagent formulations can be prepared from the enzymes, reagents and the substances already mentioned and can be mixed as solutions or powders or in the form of tablets or lyophilizates. If the reagent formulation is not already in solution, it can be dissolved in water or other suitable solution, by which the reagent solution is prepared. If the reagent formulation consists of the individual components, these are mixed with one another. After mixing the sample (eg substrate solution, enzyme solution, serum, plasma or urine) with a portion of the reagent mixture, the resulting color is measured with a photometer. The specific concentration, or substrate concentration, is then calculated from the molar extinction coefficient and the amount of reagent or sample added. Both dynamic and endpoint measurements are possible.
Fe3+/リガンド系を、 1.特定のパラメーター検出に必要な1以上の試薬又は
他の酵素; 2.緩衝系; 3.湿潤剤; 4.活性化剤;及び、 5.他の助剤 と共に吸収性試薬担持体(例えば紙、フリースなど)上
に含浸せしめることもできる。これについては、試薬又
は助剤がどの程度溶解するかによって、水溶液、有機溶
液又は混合溶液の形態で1以上の含浸溶液を調製するこ
とができる。Fe 3+ / ligand system 1. one or more reagents or other enzymes required for specific parameter detection; Buffer system; 3. 3. Wetting agent; 4. an activator; and It can also be impregnated onto an absorbent reagent carrier (eg, paper, fleece, etc.) together with other auxiliaries. For this, one or more impregnation solutions can be prepared in the form of aqueous solutions, organic solutions or mixed solutions, depending on how well the reagents or auxiliaries are dissolved.
吸収性又は膨潤性担持体、好ましくは紙、又はガラス
もしくはプラスチックの吸収性フリースにこれらの溶液
を含浸又は噴霧し、次に乾燥する。このようにして製造
された試薬担持体を、液体試料、すなわち、血液、尿も
しくは唾液のような体液、又は果汁、牛乳などのような
食品の含有物を直接測定するための迅速診断薬として用
いることもできる。それによって液体を試薬担持体に直
接施すか、又は担持体を液体中に短時間浸漬する。比較
用の色を、このようにして生成した色に対して配置する
ことによって半定量的分析が可能である。定量的分析は
反射光度計によって行なうことができる。Absorbent or swellable supports, preferably paper or absorbent fleeces of glass or plastic, are impregnated or sprayed with these solutions and then dried. The reagent carrier produced in this manner is used as a rapid diagnostic agent for directly measuring a liquid sample, that is, a body fluid such as blood, urine or saliva, or the content of food such as fruit juice or milk. You can also The liquid is thereby applied directly to the reagent carrier or the carrier is immersed in the liquid for a short time. Semi-quantitative analysis is possible by arranging the comparative colors against the colors thus generated. Quantitative analysis can be performed with a reflectance photometer.
本発明による試験用試薬を、注型成形用溶液から製造さ
れる担体マトリクス中に組み込むことも可能である。こ
こで示しうる例は、セルロース、セルロース誘導体、ゼ
ラチン、ゼラチン誘導体、又はポリウレタン及びアクリ
ルアミドのようなプラスチックである。ここで、試験用
試薬、及び、適当な場合には他の必要な試薬を注型成形
用溶液に直接加えると有利である。それによって、一つ
の操作で担体及び試薬からなる試験具を製造することが
できる。It is also possible to incorporate the test reagents according to the invention into a carrier matrix prepared from a casting solution. Examples which may be mentioned here are cellulose, cellulose derivatives, gelatin, gelatin derivatives or plastics such as polyurethane and acrylamide. Here, it is advantageous to add the test reagents and, where appropriate, other necessary reagents directly to the casting solution. Thereby, the test device including the carrier and the reagent can be manufactured by one operation.
上記記載の試薬を、水又は緩衝剤又は血清によって吸収
性担体から溶出せしめることによって試薬溶液を得るこ
とができる。次に基質又は酵素を上記記載のように光度
計のセル中で測定することができる。A reagent solution can be obtained by eluting the above-described reagent from the absorbent carrier with water or a buffer or serum. The substrate or enzyme can then be measured in the photometer cell as described above.
記載された試験用試薬に好適な緩衝剤は、アルカリ金属
又はアンモニウム対向イオンを有するリン酸塩、クエン
酸塩、ホウ酸塩、及びGOOD緩衝剤である。しかしな
がら他の系を用いることもできる。pH6.5〜7.5が
好ましいが、目的とするpH値は6〜10である。Suitable buffers for the test reagents described are phosphate, citrate, borate, and GOOD buffers with alkali metal or ammonium counterions. However, other systems can be used. A pH value of 6 to 10 is desired although pH 6.5 to 7.5 is preferable.
湿潤剤は、本発明による化合物とイオン性相互作用を起
こすアニオン及びカチオン湿潤剤が特に好ましい。酵素
を活性化する非イオン湿潤剤を用いることもでき、ラウ
リル硫酸ナトリウム、ジオクチルスルホコハク酸ナトリ
ウム及びアルキルアリールポリエーテルアルコール類が
好ましい。Wetting agents are particularly preferred anionic and cationic wetting agents which undergo an ionic interaction with the compounds according to the invention. Non-ionic wetting agents which activate the enzyme can also be used, sodium lauryl sulphate, sodium dioctyl sulfosuccinate and alkylaryl polyether alcohols being preferred.
用いることができるエフェクターは特定の酵素反応に関
して公知のものである。Effectors that can be used are known for particular enzymatic reactions.
適当な他の助剤は、他の色原体を用いた対応する試験に
おいて公知のもののような、通常の増粘剤、可溶化剤、
乳化財、光学的増白剤、一定媒体などである。Suitable other auxiliaries are the usual thickeners, solubilizers, such as those known in the corresponding tests with other chromogens.
Examples include emulsified goods, optical brighteners, and fixed media.
実施例 FeCl3及び錯体リガンドによるチオールの分析 記載された試験系においてNADHを検出するために、
次の試薬成分をセル中に入れた。Example Analysis of thiols with FeCl 3 and complex ligands To detect NADH in the test system described,
The following reagent components were placed in the cell.
試薬ブランク値を測定後、NADH溶液20μを加え
ることによって反応を開始させた。515nmにおいて
最大吸光度が測定された。動的測定によって、僅か1時
間の反応時間後に安定な終了点(20分以内の吸光度変
化が1%)が示された。 After measuring the reagent blank value, the reaction was started by adding 20 μ of NADH solution. The maximum absorbance was measured at 515 nm. Dynamic measurements showed a stable end point (1% change in absorbance within 20 minutes) after a reaction time of only 1 hour.
作用能力及び直線性を試験するために、1〜10ミリモ
ル/の範囲のNADH濃度を回分試験で測定した。5
15nmにおいて測定した吸光度の違いを表1に示し
た。In order to test the potency and linearity, NADH concentrations in the range of 1-10 mmol / ml were determined in batch tests. 5
The difference in the absorbance measured at 15 nm is shown in Table 1.
種々の錯体リガンドを用いて得られる色、及び対応する
最大吸光度を表2に示した。 The colors obtained with various complex ligands and the corresponding maximum absorbances are shown in Table 2.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 G01N 33/68 7055−2J (56)参考文献 特開 昭61−153564(JP,A) 日本分析化学会編分析化学便覧丸善昭和 46年P.430−433─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical indication location G01N 33/68 7055-2J (56) Reference JP-A-61-153564 (JP, A) Japanese analysis Analytical Chemistry Handbook by the Society of Chemistry Maruzen 1972 430-433
Claims (2)
るチオール化合物の量と等量の鉄、及び、 +2の酸化状態の鉄と選択的に錯体を形成することがで
き、それによって該鉄との錯体形成に基づく色変化を示
すリガンドからなることを特徴とする、液体試料中のチ
オール化合物、又はチオール化合物の存在に関連する物
質を比色分析するための分析試験用試薬。1. A complex which can be selectively formed with iron in the +3 oxidation state and at least as much as the amount of the thiol compound to be detected, and +2 in the oxidation state, whereby the iron and the iron can be selectively formed. A reagent for an analytical test for colorimetrically analyzing a thiol compound in a liquid sample or a substance related to the presence of the thiol compound, which comprises a ligand that exhibits a color change based on the complex formation.
の酸化状態の鉄と選択的に錯体を形成することができ、
それによって、+2の酸化状態のかかる鉄イオンとの錯
体形成により、色変化を起こすリガンドからもなってい
る液と、液体試料を一緒にすることを特徴とする、液体
試料中のチオール化合物、又はチオール化合物の存在に
関連する物質の分析方法。2. Iron consisting of +3 oxidation state and +2
Can form a complex selectively with iron in the oxidation state of
A thiol compound in a liquid sample, characterized in that the liquid sample is combined with a liquid which also comprises a ligand which causes a color change by complex formation with such iron ions in the +2 oxidation state, or A method for analyzing a substance related to the presence of a thiol compound.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873703081 DE3703081A1 (en) | 1987-02-03 | 1987-02-03 | METHOD AND MEANS FOR DETECTING THIOLES |
| DE3703081.7 | 1987-02-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63247656A JPS63247656A (en) | 1988-10-14 |
| JPH0635966B2 true JPH0635966B2 (en) | 1994-05-11 |
Family
ID=6320068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63021427A Expired - Lifetime JPH0635966B2 (en) | 1987-02-03 | 1988-02-02 | Analytical reagent useful for detecting thiol compound and detection method using the same |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPH0635966B2 (en) |
| CA (1) | CA1339797C (en) |
| DE (1) | DE3703081A1 (en) |
| FR (1) | FR2610409B1 (en) |
| GB (1) | GB2200989B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5190863A (en) * | 1990-06-29 | 1993-03-02 | Miles Inc. | Composition for determining the presence or concentration of D-β-hydroxybutyrate |
| EP1120648B1 (en) * | 1998-09-10 | 2008-06-25 | FUJIFILM Corporation | Method of detecting thiol-containing compound |
| TW546475B (en) | 1998-12-07 | 2003-08-11 | Daiichi Pure Chemicals Co Ltd | A method for quantifying hydrogen sulfide or sulfide ion and a method for quantifying homocysteine or cysteine by using the method |
| KR20070004963A (en) * | 2004-04-29 | 2007-01-09 | 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 | Use of metal complexes with bispyridylpyrimidine or bispyridyltriazine ligands as catalysts for reaction with peroxy compounds to bleach colored stains on hard surfaces |
| GB0712844D0 (en) | 2007-07-02 | 2007-08-08 | Univ Leuven Kath | Colorimetric assay for the visual detection of primary and secondary amines |
| CA2764617A1 (en) * | 2009-06-08 | 2010-12-16 | Protea Biopharma N.V. | Methods and kits for detecting, diagnosing and monitoring diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3709662A (en) * | 1970-07-20 | 1973-01-09 | Hach Chemical Co | Iron analysis reagent formulation |
| US4245041A (en) * | 1977-12-07 | 1981-01-13 | American Monitor Corporation | Triglycerides assay and reagents therefor |
| IT1167660B (en) * | 1983-09-28 | 1987-05-13 | Sclavo Spa | METHOD AND REACTIVE COMPOSITIONS SUITABLE FOR COLORIMETRIC DETERMINATION OF METALS |
| JPS61153564A (en) * | 1984-12-26 | 1986-07-12 | Kao Corp | Quantitative determination of iron in water and reagent for quantitative determination to be used for there |
| US4701420A (en) * | 1985-04-01 | 1987-10-20 | Eastman Kodak Company | Analytical compositions, elements and methods utilizing reduction of ferric ion chelates to form detectable dyes |
-
1987
- 1987-02-03 DE DE19873703081 patent/DE3703081A1/en not_active Withdrawn
-
1988
- 1988-01-13 CA CA000556460A patent/CA1339797C/en not_active Expired - Fee Related
- 1988-01-26 FR FR8800862A patent/FR2610409B1/en not_active Expired - Fee Related
- 1988-01-28 GB GB8801876A patent/GB2200989B/en not_active Expired - Fee Related
- 1988-02-02 JP JP63021427A patent/JPH0635966B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| 日本分析化学会編分析化学便覧丸善昭和46年P.430−433 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2200989A (en) | 1988-08-17 |
| FR2610409A1 (en) | 1988-08-05 |
| JPS63247656A (en) | 1988-10-14 |
| FR2610409B1 (en) | 1994-05-13 |
| GB8801876D0 (en) | 1988-02-24 |
| GB2200989B (en) | 1991-05-22 |
| DE3703081A1 (en) | 1988-08-11 |
| CA1339797C (en) | 1998-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4929545A (en) | Method and reagent for determination of an analyte via enzymatic means using a ferricyanide/ferric compound system | |
| Matsubara et al. | Spectrophotometric determination of hydrogen peroxide with titanium 2-((5-bromopyridyl) azo)-5-(N-propyl-N-sulfopropylamino) phenol reagent and its application to the determination of serum glucose using glucose oxidase | |
| JPH0577399B2 (en) | ||
| US4425427A (en) | Simultaneous, kinetic, spectrophotometric analysis of blood serum for multiple components | |
| JPH11504808A (en) | Measurement of glycated protein | |
| US4143080A (en) | Method and reagent for the assay of hydroperoxide | |
| Watts | Determination of uric acid in blood and in urine | |
| CA1319594C (en) | Process and reagent for the determination of fructosamine in body fluids | |
| EP0681611B1 (en) | Compositions useful in anaerobic determination of analytes | |
| JPH0635966B2 (en) | Analytical reagent useful for detecting thiol compound and detection method using the same | |
| EP0159355A1 (en) | Device for rapid quantitative analysis of a fluid | |
| EP0396584B1 (en) | Assay of salicylates or reduced pyridine nucleotides | |
| EP0570588A1 (en) | Method and reagent for determination of serum iron or unsaturated iron binding capacity | |
| JP3127160B2 (en) | Improved methods and reagents for measuring an analyte | |
| JPH0391494A (en) | Enzymatic measuring method for concentration of constituents of substance undergoing analysis | |
| JP2694004B2 (en) | Method for measuring fructosamine in serum or plasma | |
| US7407774B2 (en) | Method for reducing influence of hemoglobin with albumin in an assay | |
| EP0665896B1 (en) | Stable reagent for ferric ion complex indicator systems | |
| JP4104393B2 (en) | Method for quantifying specific components in biological sample and reagent for quantification | |
| JP2761768B2 (en) | Method for determining NADH and method for determining bile acid using the same | |
| JPS63214199A (en) | Enzyme assay of biological substance | |
| JPH0755160B2 (en) | Method and reagent for enzymatically measuring creatinine | |
| JPS61173799A (en) | Method of determining activity of substrate or enzyme | |
| JPH0343096A (en) | Determination of substrate or enzyme | |
| JPH0510956A (en) | Method for measuring constituent within living organism sample |